# TIVOZANIB
> **ANDA220437** · Abbreviated New Drug Application (Generic) · Sponsor: SANDOZ INC · Approved 2026-05-14
## Drug
- **FDA Application Number:** ANDA220437
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TIVOZANIB
- **Generic name:** Tivozanib
- **Active ingredients:** TIVOZANIB
- **Dosage form:** CAPSULE
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SANDOZ INC
- **First approval:** 2026-05-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=220437)
---
*MORVS · CC0 1.0*